DISEASE & DISORDERS

Addiction, dopamine, and the molecular mechanisms of memory dopamine and Addiction Personality, Addiction, dopamine: insights from Parkinson’s disease Reward system and Addiction: what dopamine does and doesn’t do The dopamine hypothesis of drug Addiction: hypodopaminergic state Roles for nigrostriatal—not just mesocorticolimbic—dopamine in reward and Addiction dopamine in drug abuse and Addiction: results from imaging studies […]

The impact of STRESS on ADDICTION A role for brain STRESS systems in ADDICTION ADDICTION as a STRESS surfeit disorder Relationships among smartphone ADDICTION, STRESS, academic performance, and satisfaction with life The role of STRESS in ADDICTION relapse STRESS as a common risk factor for obesity and ADDICTION STRESS, habits, and drug ADDICTION: a psychoneuroendocrinological

Regulation of mTORC2 signaling New insights into mTOR signaling: mTORC2 and beyond mTORC2 in the center of cancer metabolic reprogramming Activation of mTORC2 by association with the ribosome Localization of mTORC2 activity inside cells Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity mTORC2

Why STRESS is bad for your BRAIN STRESS and BRAIN noradrenaline: a review The STRESS gene response in BRAIN. STRESS, the aging BRAIN, and the mechanisms of neuron death. STRESS and immunity: an integrated view of relationships between the BRAIN and the immune system Pattern and time course of immediate early gene expression in rat

Prognostic significance of HYPERGLYCEMIA in acute stroke HYPERGLYCEMIA in mental disorders The relationship of cardiovascular disease to HYPERGLYCEMIA The effect of acute HYPERGLYCEMIA on gastric emptying in man Moderate HYPERGLYCEMIA augments ischemic brain damage: a neuropathologic study in the rat Regional cerebral blood flow decreases during HYPERGLYCEMIA Regulation of splanchnic and peripheral glucose uptake by

Glycotoxines, Carbonyl Stress and relevance to diabetes and its complications. Reactive Carbonyl compounds related uremic toxicity (“Carbonyl Stress ”) Carbonyl Stress in the pathogenesis of diabetic nephropathy Relevance of oxidative and Carbonyl Stress to long-term uremic complications Carbonyl Stress and schizophrenia Alterations in nonenzymatic biochemistry in uremia: origin and significance of “Carbonyl Stress ” in

CARBAMYLATION-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis CARBAMYLATION and antibodies against carbamylated proteins in autoimmunity and other pathologies Protein CARBAMYLATION in kidney disease: pathogenesis and clinical implications Protein CARBAMYLATION and cardiovascular disease Citrullination and CARBAMYLATION in the pathophysiology of rheumatoid arthritis Myeloperoxidase-mediated lipoprotein CARBAMYLATION as a mechanistic pathway for

Harnessing NEUROPLASTICITY for clinical applications NEUROPLASTICITY in children Conceptualizing functional NEUROPLASTICITY Homer2 is necessary for EtOH-induced NEUROPLASTICITY Stress, depression, and NEUROPLASTICITY: a convergence of mechanisms Threoretical aspects of NEUROPLASTICITY Toward a theory of NEUROPLASTICITY Antidepressants and NEUROPLASTICITY Mitochondria and NEUROPLASTICITY Central NEUROPLASTICITY and pathological pain NEUROPLASTICITY subserving motor skill learning NEUROPLASTICITY mediated by altered gene

Glycation and diabetic complications Role of glycation in aging Mechanisms of glycation in atherogenesis The pathological implications of protein glycation. Glycation products and the pathogenesis of diabetic complications Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes Advanced glycation end-products and atherosclerosis Inhibition of protein glycation and advanced glycation end